These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9816363)

  • 1. Heart failure with fludrocortisone in Addison's disease.
    Bhattacharyya A; Tymms DJ
    J R Soc Med; 1998 Aug; 91(8):433-4. PubMed ID: 9816363
    [No Abstract]   [Full Text] [Related]  

  • 2. Fludrocortisone induced heart failure in Addison's disease.
    Willis FR; Byrne GC; Jones TW
    J Paediatr Child Health; 1994 Jun; 30(3):280-1. PubMed ID: 8074919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison's disease: a case report.
    Campean R; Hasun M; Stöllberger C; Bucher J; Finsterer J; Schnack C; Weidinger F
    J Med Case Rep; 2016 Oct; 10(1):281. PubMed ID: 27729057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological action of 9alpha-fluorohydrocortisone as a mineralocorticoid].
    Sekihara H
    Nihon Rinsho; 1994 Mar; 52(3):583-6. PubMed ID: 8164353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudotumor cerebri: a presenting manifestation of Addison's disease.
    Condulis N; Germain G; Charest N; Levy S; Carpenter TO
    Clin Pediatr (Phila); 1997 Dec; 36(12):711-3. PubMed ID: 9415840
    [No Abstract]   [Full Text] [Related]  

  • 7. Addison's Disease and Pituitary Enlargement.
    Winters SJ; Vitaz T; Nowacki MR; Craddock DC; Silverman C
    Am J Med Sci; 2015 Jun; 349(6):526-9. PubMed ID: 25004119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of Addison's disease].
    Tiede N; Hofbauer LC; Bornstein SR; Kirch W
    Dtsch Med Wochenschr; 2010 Aug; 135(31-32):1561-2. PubMed ID: 20665422
    [No Abstract]   [Full Text] [Related]  

  • 9. Addison's disease presenting with acute kidney injury.
    Connor A; Care S; Taylor J
    Clin Med (Lond); 2010 Oct; 10(5):515-6. PubMed ID: 21117391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First presentation of Addison's disease in the 2nd trimester of pregnancy.
    Mittal A; Dexter S; Marcus S; Tremble J
    J Obstet Gynaecol; 2011 May; 31(4):342. PubMed ID: 21534762
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating levels of adrenomedullin in patients with Addison's disease before and after corticosteroid treatment.
    Letizia C; Cerci S; Centanni M; De Toma G; Subioli S; Scuro L; Scavo D
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):145-8. PubMed ID: 9579224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement therapy for Addison's disease: recent developments.
    Løvås K; Husebye ES
    Expert Opin Investig Drugs; 2008 Apr; 17(4):497-509. PubMed ID: 18363515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9-alpha-Fluorohydrocortisone-induced hypertension in a male infant with adrenogenitalism, and in 6 adults with Addison's disease.
    ENGEL FL; OWEN JA; WESTER TB
    J Clin Endocrinol Metab; 1957 Feb; 17(2):272-9. PubMed ID: 13398467
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence that patients with Addison's disease are undertreated with fludrocortisone.
    Smith SJ; MacGregor GA; Markandu ND; Bayliss J; Banks RA; Prentice MG; Dorrington-Ward P; Wise P
    Lancet; 1984 Jan; 1(8367):11-4. PubMed ID: 6140341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency.
    Wasniewska M; Valenzise M; Aversa T; Mirabelli S; De Luca F; De Luca FL; Lombardo F
    J Endocrinol Invest; 2011 Feb; 34(2):159-61. PubMed ID: 21502797
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic fatigue syndrome and Addison's disease.
    Baschetti R
    J Pediatr; 2003 Feb; 142(2):217; author reply 217-8. PubMed ID: 12584556
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
    Petersen KS; Rushworth RL; Clifton PM; Torpy DJ
    BMC Endocr Disord; 2015 Oct; 15():61. PubMed ID: 26500000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective health status in Norwegian patients with Addison's disease.
    Løvås K; Loge JH; Husebye ES
    Clin Endocrinol (Oxf); 2002 May; 56(5):581-8. PubMed ID: 12030907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Addison's Disease Nearly Mistaken for Anorexia Nervosa.
    Feeney C; Buell K
    Am J Med; 2018 Nov; 131(11):e457-e458. PubMed ID: 30055119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.